Navigation Links
Third Circuit Denies Mylan Motion for Interim Injunction
Date:10/27/2010

PITTSBURGH, Oct. 27 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that the Third Circuit Court of Appeals denied its motion for an interim injunction pending an on-going appeal of a recent New Jersey District Court decision relating to generic Paroxetine CR. The New Jersey District Court previously denied Mylan's motion for a preliminary injunction, and the appeal of that decision will now continue before the Third Circuit. Mylan is disappointed by the decision, which does not reflect a final decision on the merits of Mylan's claims, and Mylan will continue to pursue its claims.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance
2. Endologix Reports 30% Third Quarter 2010 Revenue Growth
3. Solos Endoscopy, Inc. Revenue Grows 34.8% for Third Quarter 2010
4. Pharmos Corporation Reports 2010 Third Quarter Results
5. Delcath Systems Announces Third Quarter Progress Report Conference Call
6. Simcere Pharmaceutical Group to Announce Third Quarter 2010 Financial Results on Thursday, November 11, 2010
7. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
8. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
9. Onyx Pharmaceuticals Announces Third Quarter 2010 Financial Results Teleconference and Webcast
10. Insmed to Host Third Quarter 2010 Conference Call
11. West to Host 2010 Third Quarter Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 2017  Sysmex America, Inc., a leading provider ... as well as middleware information systems technology, today ... quality assurance easier and more risk free than ... for the innovation that it delivers to the ... assurance processes to a new level with automated, ...
(Date:7/11/2017)... 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... Administration (FDA) has agreed to schedule an End-of-Phase II ... trial of its oral insulin capsule ORMD-0801 in the ... met primary and secondary endpoints by indicating a statistically ...
(Date:7/10/2017)... , July 10, 2017 The Institute ... test methods, is the recipient of a VITROCELL® inhalation ... PETA International Science Consortium. The device, which is designed ... to expose human lung cells to airborne test materials ... will use the VITROCELL® system for testing combustible tobacco ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... July 19, 2017 , ... A July ... lead to, or worsen, varicose veins in some patients, according to medical experts. ... certain not-so-good practices, like excessive sitting or standing, or regularly nicking yourself while ...
(Date:7/20/2017)... ... July 20, 2017 , ... “Lucky the Buffalo and Her Adventures”: a collection of heartwarming ... Edward Bieniek. Edward Steven Bieniek Jr. was born in Toledo, Ohio. He attended ... com tech. He is married to a brilliant woman with a caring heart named ...
(Date:7/18/2017)... ... 2017 , ... Cognition Corporation , a software company ... of its “From the Helm” Webinar Series. , These sessions will focus ... CEO, the half-hour public webinars will take an in-depth look at applying usability ...
(Date:7/18/2017)... ... ... The results of an international clinical trial, led in part by a UC Davis School ... dystrophy holds promise for a subgroup of patients. , In a paper just published online ... study sites in 18 countries describe the clinical benefit of using the drug ataluren for ...
(Date:7/18/2017)... ... ... An inventor from Anacortes, Wash., knows the difficulties and indignity of not being ... I suffer from anxiety and vertigo on top of that," she said, "so I ... meets that need. , This device enables a woman in menopause to cool off ...
Breaking Medicine News(10 mins):